Last reviewed · How we verify

NCT00313378

Effects of Perioperative Systemic Ketamine on Development of Long-term Neuropathic Pain After Thoracotomy.

Completed Phase 3 Last updated 2 April 2013
What this trial tests

Phase 3 trial testing Hypothetica in Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy. in 78 participants. Completed in 1 May 2008.

Timeline
1 April 2004
Primary endpoint
1 May 2008
1 May 2008

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment78
Start date1 April 2004
Primary completion1 May 2008
Estimated completion1 May 2008
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

Adults 20 to 75, any sex, with Partial Pneumonectomy Under Lateral or Posterolateral Thoracotomy.. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Lung surgery under thoracotomy is known to induce long-term pain which can be considered as neuropathic in many patients concerned \[1,2\]. The suspected origin of neuropathy is a direct traumatism of intercostal nerve(s) \[3\]. Among the possible preventive treatments that can be administered during the initial aggression, ketamine \[4,5\] appears as the easiest to use, as it is already commonly administered intra and postoperatively for improvement of analgesia \[6\].

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.
    Cavalli E, Mammana S, Nicoletti F, Bramanti P, et al · · 2019 · cited 353× · PMID 30900486 · DOI 10.1177/2058738419838383
  2. NMDA receptors in clinical neurology: excitatory times ahead.
    Kalia LV, Kalia SK, Salter MW. · · 2008 · cited 307× · PMID 18635022 · DOI 10.1016/s1474-4422(08)70165-0

Verify or expand the search:

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00313378.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing